Concepedia

Charles J. Eyermann

CJ

Statistics

Publications

55

Citations

4K

H-Index

30

Active since

1982

Affiliations

AstraZeneca (United States)(Current)

South African Medical Research Council

University of Cape Town

Wilmington University

DuPont (United States)

Charles J. Eyermann is an author at AstraZeneca (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1982–2023

55

Publications

55

Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors

Patrick Y. S. Lam, Prabhakar K. Jadhav, Charles J. Eyermann et al. · Science · 1994 · 836 citations

, , +16

Core-electron binding energies for gaseous atoms and molecules

William L. Jolly, Kenneth D. Bomben, Charles J. Eyermann · Atomic Data and Nuclear Data Tables · 1984 · 438 citations

, , +14

Identification of 4-Substituted 1,2,3-Triazoles as Novel Oxazolidinone Antibacterial Agents with Reduced Activity against Monoamine Oxidase A

Folkert Reck, Fei Zhou, Marc Girardot et al. · Journal of Medicinal Chemistry · 2005 · 326 citations · Full text

, , +15

SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids

Jitske Jansen, Katharina C. Reimer, James S. Nagai et al. · Cell stem cell · 2021 · 266 citations · Full text

, , +17

Cyclic HIV Protease Inhibitors:  Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic Ureas

Patrick Y. S. Lam, Yu Ru, Prabhakar K. Jadhav et al. · Journal of Medicinal Chemistry · 1996 · 170 citations · Full text

, , +17

1–5 of 55